Bicocca Open Archive

Logo unimib boa
BALDUZZI, ADRIANA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.840
EU - Europa 4.218
AS - Asia 2.241
SA - Sud America 47
OC - Oceania 24
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.731
IT - Italia 910
SG - Singapore 786
IE - Irlanda 740
SE - Svezia 671
CN - Cina 659
DE - Germania 572
RU - Federazione Russa 455
HK - Hong Kong 331
UA - Ucraina 266
GB - Regno Unito 188
ID - Indonesia 125
CA - Canada 97
FR - Francia 88
VN - Vietnam 87
FI - Finlandia 78
IN - India 78
BE - Belgio 46
JP - Giappone 45
NL - Olanda 42
TR - Turchia 41
IR - Iran 32
BR - Brasile 30
DK - Danimarca 27
ES - Italia 26
AU - Australia 17
AT - Austria 15
PL - Polonia 13
CZ - Repubblica Ceca 12
MX - Messico 12
LT - Lituania 11
TW - Taiwan 11
EG - Egitto 10
BG - Bulgaria 9
CH - Svizzera 8
GR - Grecia 8
IL - Israele 8
KR - Corea 8
PH - Filippine 8
AR - Argentina 7
NZ - Nuova Zelanda 7
LA - Repubblica Popolare Democratica del Laos 6
CL - Cile 5
NO - Norvegia 5
PT - Portogallo 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
EU - Europa 4
KZ - Kazakistan 4
LV - Lettonia 4
NG - Nigeria 4
PE - Perù 4
RO - Romania 4
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
EE - Estonia 2
MU - Mauritius 2
MY - Malesia 2
SI - Slovenia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CO - Colombia 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
TG - Togo 1
TN - Tunisia 1
Totale 16.398
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Fairfield 1.011
Woodbridge 810
Dublin 717
Singapore 691
Wilmington 591
Chandler 524
Ashburn 469
Houston 468
Seattle 437
Frankfurt am Main 400
Hong Kong 326
Santa Clara 297
Cambridge 287
Dearborn 286
New York 263
Jacksonville 259
Princeton 232
Milan 229
Jakarta 122
Lawrence 113
Beijing 96
Shanghai 96
Nanjing 94
Altamura 92
San Diego 74
Andover 47
Rome 45
Dong Ket 37
Lachine 36
Fremont 35
Nanchang 32
Brussels 31
Helsinki 31
Chicago 29
Lissone 28
Toronto 28
Boardman 27
London 26
Hebei 25
Guangzhou 24
Changsha 22
Hangzhou 22
Tianjin 21
Kocaeli 20
Jinan 19
Mountain View 19
Shenyang 19
Redmond 18
Munich 17
Turin 17
Jiaxing 16
Florence 15
Dallas 14
Falls Church 14
Paris 14
São Paulo 14
Monza 13
San Mateo 13
Huizen 12
Los Angeles 12
Naples 12
Bologna 11
Brescia 11
Ottawa 11
Pune 11
Norwalk 10
Washington 10
Zhengzhou 10
Hefei 9
Lappeenranta 9
Plovdiv 9
Arakawa 8
Brno 8
Caltanissetta 8
Chengdu 8
Ningbo 8
Tokyo 8
Vilnius 8
Auckland 7
Catania 7
Ghent 7
Hanoi 7
Hounslow 7
Pisa 7
Romola 7
Saint Petersburg 7
Zanjan 7
Amsterdam 6
Cinisello Balsamo 6
Desio 6
Kiev 6
Kilburn 6
Kunming 6
Marseille 6
Moscow 6
Nürnberg 6
Santa Croce Camerina 6
University Park 6
Valencia 6
Totale 12.276
Salva come PNG Salva come JPEG
Nome #
ABO incompatibile graft management in pediatric transplantation 364
Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations 357
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 321
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 307
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 277
Avascular necrosis of the talus in pediatric acute lymphoblastic leukemia: Current concepts 271
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 263
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 258
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 240
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 240
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 236
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 230
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 217
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 214
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: Practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group 210
Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload 209
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 204
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 204
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 200
State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015 195
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. 189
Long-term effects of bone marrow transplantation on dental status in children with leukaemia 189
Donor selection in Adults and Pediatrics 184
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 183
TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission 172
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention? 172
CD34(+) stem cell recovery after positive selection of "overloaded" immunomagnetic columns 169
A novel homozygous disruptive PRF1 variant (K285Sfs*4) causes very early-onset of familial hemophagocytic lymphohystiocytosis type 2 166
Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease 164
Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience 162
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia 160
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 159
Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission 158
High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case 158
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 158
Thyroid disorders following hematopoietic stem cell transplantation in childhood: the impact of the conditioning regimen on thyroid dysfunction, volume changes and occurrence of nodules 158
Transplant-related toxicity and mortality: An AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia 147
Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment 146
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (vhr) childhood acute lymphoblastic leukaemia in first complete remission 145
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study 142
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 141
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 141
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: The impact of the waiting time 141
Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation 139
Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? 137
A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization 137
Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission 134
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial 134
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG 130
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: A new classification from the European society for blood and marrow transplantation 129
Effectiveness of extracorporeal photochemotherapy in treating long-term refractory chronic graft-versus-host disease 128
The impact of MRD in HCT for childhood ALL 127
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 126
Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL 126
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study 124
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children 124
When to suspect GATA2 deficiency in pediatric patients: from complete blood count to diagnosis 124
Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions 123
Tetralogy of Fallot with absent pulmonary valve: definitive diagnosis by two-dimensional echocardiography 122
Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation 122
Pentraxin-3 Increases At The Onset Of Graft-Versus-Host Disease In Transplanted Patients 120
Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study 120
Questions on chimerism analysis after stem cell transplantation 118
COVID-19 in Immunosuppressed Children 115
Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome 111
Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes 111
Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: A study from the infectious diseases working party of the european group for blood and marrow transplantation 111
Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study 107
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) 106
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 105
Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases 105
Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), Italy 105
Two pregnancies shortly after transplantation with reduced intensity conditioning in chronic myeloid leukemia 104
Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen 104
More precisely defining risk peri-HCT in pediatric ALL: Pre- vs post-MRD measures, serial positivity, and risk modeling 104
Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP) 104
Bone marrow transplantation for childhood hematological disorders: a global pediatric approach in a twelve year single center experience 103
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing 101
Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: A report from the AIEOP registry 97
Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies 94
Unrelated Donor Marrow Transplantation in Children 92
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study 92
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range 90
Minimal residual disease assessment by next-generation sequencing. Better tools to gaze into the crystal ball? 90
Guidance to Bone Morbidity in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Bone Morbidity in Children after HSCT 90
Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMT 89
Molecular diagnosis of skin relapse in acute lymphoblastic leukemia 88
The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global 88
Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up 87
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial 86
Imatinib for refractory chronic graft-versus-host disease with fibrotic features 86
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: Impact of center size: An analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group 86
Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia-Positive Acute Lymphoblastic Leukemia in Children and Adolescents: A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP) 86
Pediatric acute graft-versus-host disease prophylaxis and treatment: surveyed real-life approach reveals dissimilarities compared to published recommendations 85
More chronic GvHD and non-relapse mortality after peripheral blood stem cell compared with bone marrow in hematopoietic transplantation for paediatric acute lymphoblastic leukemia: A retrospective study on behalf of the EBMT Paediatric Diseases Working Party 84
The Value of Minimal Residual Disease (and Diamonds) 83
Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment 81
No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission 80
Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells? 79
The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test 79
Totale 14.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.514 0 0 0 0 0 329 326 243 257 155 147 57
2020/20212.846 135 187 267 259 307 276 278 222 190 270 190 265
2021/20221.750 158 231 229 159 78 113 74 86 129 122 130 241
2022/20232.682 318 716 163 186 225 418 53 195 217 25 92 74
2023/20242.385 77 69 133 123 300 544 458 88 238 54 77 224
2024/20252.597 345 882 361 307 455 247 0 0 0 0 0 0
Totale 17.207